R Lobefaro, E Zattarin,
F Nichetti… - Therapeutic …, 2020 - journals.sagepub.com
Background: Neoadjuvant anthracycline-taxane-based chemotherapy (ChT) is a standard of
care treatment option for stage II–III breast cancer (BC) patients. However, the optimal …